Despite growing recognition of biomarker testing, access to evidence-based biomarker testing remains surprisingly fragmented.
Healthcare delivery in the United States is highly decentralized. Physicians, laboratories, hospitals, specialists, and payors typically operate as independent organizations with different workflows, systems, incentives, and areas of expertise. While many laboratories market advanced biomarker testing, the existence of a laboratory test alone does not ensure that the test is being utilized consistently, interpreted appropriately, or incorporated into a structured clinical decision-making process.
The Challenge in Delivering Biomarker-Informed Care
In many cases, providers may be unfamiliar with emerging biomarker technologies, laboratories may lack access to relevant clinical context, and patients may encounter significant barriers when attempting to navigate the various clinical, administrative, and logistical steps required to access testing. As a result, many potentially valuable diagnostic technologies never achieve widespread adoption within routine clinical practice, even when supported by promising scientific evidence.
The challenge is often not the availability of a specific lab test – it is the absence of a scalable, repeatable framework that enables physicians, laboratories, and other stakeholders to apply testing consistently within evidence-based clinical workflows. A laboratory result generated in isolation may provide limited value if there is no consistent framework governing when testing should be considered, how results should be interpreted, what clinical information should be reviewed, or how findings should be integrated into patient care.
Why Evidence-Based Clinical Pathways Matter
For this reason, many areas of medicine increasingly rely upon evidence-based clinical pathways. These pathways establish structured frameworks that help ensure diagnostic technologies are applied consistently across patients, providers, and clinical settings.
Well-designed clinical pathways may include:
- Defined clinical indications for testing
- Provider education and pathway-specific training
- Standardized clinical workflows
- Consistent documentation requirements
- Independent provider decision-making
- Structured interpretation methodologies
- Multidisciplinary review and consultation processes
- Ongoing quality oversight and pathway governance
By creating a repeatable framework for clinical application, evidence-based pathways help reduce variability, promote adherence to best practices, and improve the consistency with which diagnostic technologies are incorporated into patient care.
As precision medicine continues to evolve, the future of healthcare will increasingly depend not only on the development of new diagnostic technologies and definitions around how to apply these via evidence-based protocols, but also on the ability to effiently connect the disparate parts - the data and subspecialist resources required to support consistent clinical adoption, broad access to care, low cost, and meaningful patient outcomes.
Building the Infrastructure for Evidence-Based Care
BioConnetiX created a platform and administrative support infrastructure designed to enable the delivery and management of evidence-based clinical pathways that bring together participating providers, laboratories, specialists, and administrative stakeholders within a coordinated framework.
These pathways are designed to support the consistent application and interpretation of advanced diagnostic technologies – including protein biomarker testing, molecular and genomic diagnostics, cell-free DNA (cfDNA) analysis, multi-analyte laboratory testing, and other precision medicine methodologies – when independently determined to be medically appropriate by treating providers and applied within defined clinical indications for testing.
The Role of the Clinical Advisory Board
At the center of each pathway is a physician-led Clinical Advisory Board (CAB) responsible for pathway development, quality oversight, and ongoing governance. Drawing upon principles commonly utilized by leading academic medical centers and integrated healthcare systems, the CAB establishes evidence-based pathway parameters designed to promote clinical utility, scientific validity, consistency of application, and multidisciplinary collaboration.
By combining pathway-specific provider education, standardized workflows, coordinated administrative infrastructure, integrated records management, and access to specialized expertise, BioConnetiX helps create a scalable framework for delivering evidence-based care. The objective is not simply to make diagnostic technologies available, but to support their consistent utilization, interpretation, and integration into broader patient management strategies.
Evidence-Based Pathways in Practice – The BioConnetiX TBI Biomarker Pathway
The BioConnetiX TBI Biomarker Pathway illustrates this approach in practice – integrating provider evaluation, diagnostic testing, physician interpretation, specialist consultation, administrative coordination, and pathway governance into a unified clinical process.
Expanding Access to Specialized Clinical Expertise
Participating Providers within a pathway are designed to expand access to specialized expertise that may otherwise be available only through large academic medical centers or research-based healthcare systems.
Within the TBI Biomarker Pathway, for example, patients may be evaluated by Participating Providers with specialized expertise in neurotrauma, including neurointensivists and other neurologic subspecialists experienced in the diagnosis and management of traumatic brain injury. Participating Providers with specialized expertise in the clinical interpretation of pathway-aligned laboratory tests provide interpretation services. Any Treating Provider involved in the patient's care may access subspecialty consultation when clinically appropriate to support diagnostic decision-making, multidisciplinary care planning, and other physician-to-physician clinical collaboration.
Aligning Laboratory Testing with Clinical Pathways
The same principles extend to laboratory participation. BioConnetiX is not affiliated with, nor dependent upon, a single laboratory provider. Instead, the Clinical Advisory Board establishes pathway requirements based upon scientific evidence, clinical utility, and evolving standards of care. Qualified laboratories are then selected based on their ability to perform testing that aligns with the pathway's clinical objectives, analytical requirements, and quality standards.
The Value of the Pathway
This distinction is important. The value of an evidence-based pathway does not arise from any single provider, laboratory, biomarker, or technology. Rather, it arises from the ability to apply clinically relevant diagnostic tools within a structured framework that promotes consistency, education, quality oversight, independent clinical judgment, and multidisciplinary collaboration.
The Challenge is No Longer Innovation; It is Implementation
As precision medicine continues to advance, the greatest challenge may no longer be the development of new diagnostic technologies, but the ability to deploy those technologies consistently in real-world clinical practice. Access to the benefits of precision medicine will increasingly depend upon platforms such as BioConnetiX that connect patients and providers with specialized clinical expertise and provide the infrastructure necessary to support evidence-based pathways, consistent clinical adoption, and efficient administrative coordination.